Brief: Orchard Therapeutics Appoints Company Founder Bobby Gaspar As New Chief Executive Officer
18/03/2020 11:33
March 18 (Reuters) - Orchard Therapeutics PLC ORTX.O :
* ORCHARD THERAPEUTICS APPOINTS COMPANY FOUNDER AND GENE
THERAPY
PIONEER BOBBY GASPAR, M.D., PH.D., AS NEW CHIEF EXECUTIVE
OFFICER
* ORCHARD THERAPEUTICS PLC - FRANK THOMAS TAKES ON
ADDITIONAL
RESPONSIBILITIES AS PRESIDENT AND COO
* ORCHARD THERAPEUTICS PLC - BOBBY GASPAR SUCCEEDS MARK
ROTHERA AS
CEO
Source text for Eikon: ID:nGNX2JpwH9
Further company coverage: ORTX.O
((Briefs@thomsonreuters.com;))
Recent news on Orchard Therapeutics
See all newsBrief: Orchard Therapeutics Says Court Of Justice Of England & Wales Sanctioned Scheme Of Arrangement Providing For Acquisition Of Co By Kyowa Kirin Co's Unit
Brief: Orchard Therapeutics Receives U.S. FDA Fast Track Designation For OTL-203 In MPS-IH
Brief: Orchard Therapeutics Says U.S. FDA Advised Co It Does Not Intend To Schedule Advisory Committee Meeting
Orchard Therapeutics rises on buyout deal by Japanese drugmaker
Kyowa Kirin to acquire Orchard Therapeutics for $478 mln